Clinical practice guideline and real-life practice in hepatocellular carcinoma: A Korean perspective
Hepatocellular carcinoma (HCC) is a major cause of death in many countries, including South Korea. To provide useful and sensible advice for clinical management of patients with HCC, the Korean Liver Cancer Association and National Cancer Center Korea Practice Guideline Revision Committee have recen...
Gespeichert in:
| Veröffentlicht in: | Clinical and molecular hepatology 2023-04, Vol.29 (2), p.197 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | kor |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 2 |
| container_start_page | 197 |
| container_title | Clinical and molecular hepatology |
| container_volume | 29 |
| creator | Myung Ji Goh Dong Hyun Sinn Jong Man Kim Min Woo Lee Dong Ho Hyun Jeong Il Yu Jung Yong Hong Moon Seok Choi |
| description | Hepatocellular carcinoma (HCC) is a major cause of death in many countries, including South Korea. To provide useful and sensible advice for clinical management of patients with HCC, the Korean Liver Cancer Association and National Cancer Center Korea Practice Guideline Revision Committee have recently revised the practice guidelines for HCC management. However, there are some differences between practice guidelines and real-life clinical practice. In this review, we describe some key recommendations of the 2022 version of practice guidelines and the real-life clinical situation in South Korea, together with discussion about efforts needed to reduce the difference between guidelines and real-life clinical practice. (Clin Mol Hepatol 2023;29:197-205) |
| format | Article |
| fullrecord | <record><control><sourceid>kiss</sourceid><recordid>TN_cdi_kiss_primary_4013603</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><kiss_id>4013603</kiss_id><sourcerecordid>4013603</sourcerecordid><originalsourceid>FETCH-kiss_primary_40136033</originalsourceid><addsrcrecordid>eNp9i7EKwjAURTMoWLRf4PJ-oFCTaIubFEVwdS_P9FUfpmlIWsG_t4Pg5nTgnntmIpGyLDJZyHIh0hj5lmtdKLXR20Q0lWXHBi34gGZgQ3AfuaFpJUDXQCC0meWWfgd28CCPQ2_I2tFiAIPBsOs73MMBLv3UOPAUoqepeNFKzFu0kdIvl2J9Ol6rc_bkGGsfuMPwrnW-Ubtcqf_2A_ohQQM</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Clinical practice guideline and real-life practice in hepatocellular carcinoma: A Korean perspective</title><source>KoreaMed Synapse</source><source>KoreaMed Open Access</source><source>DOAJ Directory of Open Access Journals</source><source>PubMed Central</source><source>PubMed Central Open Access</source><source>ProQuest Central</source><creator>Myung Ji Goh ; Dong Hyun Sinn ; Jong Man Kim ; Min Woo Lee ; Dong Ho Hyun ; Jeong Il Yu ; Jung Yong Hong ; Moon Seok Choi</creator><creatorcontrib>Myung Ji Goh ; Dong Hyun Sinn ; Jong Man Kim ; Min Woo Lee ; Dong Ho Hyun ; Jeong Il Yu ; Jung Yong Hong ; Moon Seok Choi</creatorcontrib><description>Hepatocellular carcinoma (HCC) is a major cause of death in many countries, including South Korea. To provide useful and sensible advice for clinical management of patients with HCC, the Korean Liver Cancer Association and National Cancer Center Korea Practice Guideline Revision Committee have recently revised the practice guidelines for HCC management. However, there are some differences between practice guidelines and real-life clinical practice. In this review, we describe some key recommendations of the 2022 version of practice guidelines and the real-life clinical situation in South Korea, together with discussion about efforts needed to reduce the difference between guidelines and real-life clinical practice. (Clin Mol Hepatol 2023;29:197-205)</description><identifier>ISSN: 2287-2728</identifier><language>kor</language><publisher>대한간학회</publisher><subject>Clinical practice guideline ; Diagnosis ; Hepatocellular carcinoma ; Surveillance ; Treatment</subject><ispartof>Clinical and molecular hepatology, 2023-04, Vol.29 (2), p.197</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780</link.rule.ids></links><search><creatorcontrib>Myung Ji Goh</creatorcontrib><creatorcontrib>Dong Hyun Sinn</creatorcontrib><creatorcontrib>Jong Man Kim</creatorcontrib><creatorcontrib>Min Woo Lee</creatorcontrib><creatorcontrib>Dong Ho Hyun</creatorcontrib><creatorcontrib>Jeong Il Yu</creatorcontrib><creatorcontrib>Jung Yong Hong</creatorcontrib><creatorcontrib>Moon Seok Choi</creatorcontrib><title>Clinical practice guideline and real-life practice in hepatocellular carcinoma: A Korean perspective</title><title>Clinical and molecular hepatology</title><addtitle>Clinical and Molecular Hepatology(대한간학회지)</addtitle><description>Hepatocellular carcinoma (HCC) is a major cause of death in many countries, including South Korea. To provide useful and sensible advice for clinical management of patients with HCC, the Korean Liver Cancer Association and National Cancer Center Korea Practice Guideline Revision Committee have recently revised the practice guidelines for HCC management. However, there are some differences between practice guidelines and real-life clinical practice. In this review, we describe some key recommendations of the 2022 version of practice guidelines and the real-life clinical situation in South Korea, together with discussion about efforts needed to reduce the difference between guidelines and real-life clinical practice. (Clin Mol Hepatol 2023;29:197-205)</description><subject>Clinical practice guideline</subject><subject>Diagnosis</subject><subject>Hepatocellular carcinoma</subject><subject>Surveillance</subject><subject>Treatment</subject><issn>2287-2728</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNp9i7EKwjAURTMoWLRf4PJ-oFCTaIubFEVwdS_P9FUfpmlIWsG_t4Pg5nTgnntmIpGyLDJZyHIh0hj5lmtdKLXR20Q0lWXHBi34gGZgQ3AfuaFpJUDXQCC0meWWfgd28CCPQ2_I2tFiAIPBsOs73MMBLv3UOPAUoqepeNFKzFu0kdIvl2J9Ol6rc_bkGGsfuMPwrnW-Ubtcqf_2A_ohQQM</recordid><startdate>20230401</startdate><enddate>20230401</enddate><creator>Myung Ji Goh</creator><creator>Dong Hyun Sinn</creator><creator>Jong Man Kim</creator><creator>Min Woo Lee</creator><creator>Dong Ho Hyun</creator><creator>Jeong Il Yu</creator><creator>Jung Yong Hong</creator><creator>Moon Seok Choi</creator><general>대한간학회</general><scope>HZB</scope><scope>Q5X</scope></search><sort><creationdate>20230401</creationdate><title>Clinical practice guideline and real-life practice in hepatocellular carcinoma: A Korean perspective</title><author>Myung Ji Goh ; Dong Hyun Sinn ; Jong Man Kim ; Min Woo Lee ; Dong Ho Hyun ; Jeong Il Yu ; Jung Yong Hong ; Moon Seok Choi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-kiss_primary_40136033</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>kor</language><creationdate>2023</creationdate><topic>Clinical practice guideline</topic><topic>Diagnosis</topic><topic>Hepatocellular carcinoma</topic><topic>Surveillance</topic><topic>Treatment</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Myung Ji Goh</creatorcontrib><creatorcontrib>Dong Hyun Sinn</creatorcontrib><creatorcontrib>Jong Man Kim</creatorcontrib><creatorcontrib>Min Woo Lee</creatorcontrib><creatorcontrib>Dong Ho Hyun</creatorcontrib><creatorcontrib>Jeong Il Yu</creatorcontrib><creatorcontrib>Jung Yong Hong</creatorcontrib><creatorcontrib>Moon Seok Choi</creatorcontrib><collection>Korean Studies Information Service System (KISS)</collection><collection>Korean Studies Information Service System (KISS) B-Type</collection><jtitle>Clinical and molecular hepatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Myung Ji Goh</au><au>Dong Hyun Sinn</au><au>Jong Man Kim</au><au>Min Woo Lee</au><au>Dong Ho Hyun</au><au>Jeong Il Yu</au><au>Jung Yong Hong</au><au>Moon Seok Choi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical practice guideline and real-life practice in hepatocellular carcinoma: A Korean perspective</atitle><jtitle>Clinical and molecular hepatology</jtitle><addtitle>Clinical and Molecular Hepatology(대한간학회지)</addtitle><date>2023-04-01</date><risdate>2023</risdate><volume>29</volume><issue>2</issue><spage>197</spage><pages>197-</pages><issn>2287-2728</issn><abstract>Hepatocellular carcinoma (HCC) is a major cause of death in many countries, including South Korea. To provide useful and sensible advice for clinical management of patients with HCC, the Korean Liver Cancer Association and National Cancer Center Korea Practice Guideline Revision Committee have recently revised the practice guidelines for HCC management. However, there are some differences between practice guidelines and real-life clinical practice. In this review, we describe some key recommendations of the 2022 version of practice guidelines and the real-life clinical situation in South Korea, together with discussion about efforts needed to reduce the difference between guidelines and real-life clinical practice. (Clin Mol Hepatol 2023;29:197-205)</abstract><pub>대한간학회</pub><tpages>9</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2287-2728 |
| ispartof | Clinical and molecular hepatology, 2023-04, Vol.29 (2), p.197 |
| issn | 2287-2728 |
| language | kor |
| recordid | cdi_kiss_primary_4013603 |
| source | KoreaMed Synapse; KoreaMed Open Access; DOAJ Directory of Open Access Journals; PubMed Central; PubMed Central Open Access; ProQuest Central |
| subjects | Clinical practice guideline Diagnosis Hepatocellular carcinoma Surveillance Treatment |
| title | Clinical practice guideline and real-life practice in hepatocellular carcinoma: A Korean perspective |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T21%3A41%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-kiss&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20practice%20guideline%20and%20real-life%20practice%20in%20hepatocellular%20carcinoma:%20A%20Korean%20perspective&rft.jtitle=Clinical%20and%20molecular%20hepatology&rft.au=Myung%20Ji%20Goh&rft.date=2023-04-01&rft.volume=29&rft.issue=2&rft.spage=197&rft.pages=197-&rft.issn=2287-2728&rft_id=info:doi/&rft_dat=%3Ckiss%3E4013603%3C/kiss%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_kiss_id=4013603&rfr_iscdi=true |